title: The curious case of intramuscular gold.
abstract: Controlled clinical trials, meta-analysis, and observational studies provide strong evidence of short-term gold efficacy. There is also substantial evidence for the retardation of radiographic abnormality. Although gold therapy is discontinued by most patients within 2 years of onset, a minority of patients sustain important long-term benefit.
authors.affiliation: Arthritis Research Center, St. Francis Research Institute.
authors.forename: F
authors.initials: F
authors.lastname: Wolfe
mesh_terms: D005069:Evaluation Studies as Topic; D006046:Gold / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007273:Injections, Intramuscular; D008137:Longitudinal Studies; D011859:Radiography; D012216:Rheumatic Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology; D013997:Time Factors
chemical_list: D006046:Gold